Ulrich Julius
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
- Surgery top 2%
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 94
- Lipoproteins and Cardiovascular Health 85
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 42
- Co-authors
- M Hanefeld (33 shared papers)Uta Schwanebeck (6 shared papers)Sabine Fischer (28 shared papers)Jan Schulze (7 shared papers)H Schmechel (5 shared papers)Stefan R. Bornstein (51 shared papers)Jens Pietzsch (16 shared papers)Sven Fischer (4 shared papers)
- Journals
- Atherosclerosis Supplements (62 papers)Hormone and Metabolic Research (8 papers)Atherosclerosis (7 papers)Experimental and Clinical Endocrinology & Diabetes (5 papers)Journal of Parenteral and Enteral Nutrition (3 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Ulrich Julius
164 papers receiving 3.4k citations
Ulrich Julius's Hit Papers
Peers
Comparison fields: 5 of 118
- Endocrinology, Diabetes and Metabolism 1.5k
- Surgery 1.5k
- Cardiology and Cardiovascular Medicine 735
- Clinical Biochemistry 210
- Physiology 448
Countries citing papers authored by Ulrich Julius
This map shows the geographic impact of Ulrich Julius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Julius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Julius more than expected).
Fields of papers citing papers by Ulrich Julius
This network shows the impact of papers produced by Ulrich Julius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Julius. The network helps show where Ulrich Julius may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulrich Julius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 173 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up Hit paper breakdown → | 1996 | 708 |
| 2 | 2013 | 232 | |
| 3 | 1991 | 145 | |
| 4 | 2002 | 124 | |
| 5 | 2003 | 98 | |
| 6 | 2008 | 74 | |
| 7 | 2002 | 74 | |
| 8 | 1998 | 71 | |
| 9 | Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis. | 2008 | 68 |
| 10 | 2012 | 58 | |
| 11 | 2005 | 57 | |
| 12 | 2009 | 56 | |
| 13 | 2013 | 48 | |
| 14 | 2013 | 46 | |
| 15 | 2002 | 40 | |
| 16 | 2008 | 40 | |
| 17 | 2009 | 38 | |
| 18 | 1997 | 38 | |
| 19 | 1996 | 36 | |
| 20 | 2008 | 35 |
About Ulrich Julius
Ulrich Julius is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Economics and Econometrics and Molecular Biology, having authored 173 papers that have together received 3.6k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (85 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (42 papers), Pharmaceutical Economics and Policy (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers), Cancer, Lipids, and Metabolism (12 papers), Atherosclerosis and Cardiovascular Diseases (12 papers), Diet and metabolism studies (11 papers) and Lipid metabolism and disorders (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Surgery (1.5k citations), Cardiology and Cardiovascular Medicine (735 citations), Clinical Biochemistry (210 citations) and Physiology (448 citations). Ulrich Julius has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include M Hanefeld, Uta Schwanebeck, Sabine Fischer, Jan Schulze, H Schmechel, Stefan R. Bornstein, Jens Pietzsch, Sven Fischer, Joachim Lindner and H J Ziegelasch. Their work appears in journals such as Atherosclerosis Supplements, Hormone and Metabolic Research, Atherosclerosis, Experimental and Clinical Endocrinology & Diabetes and Journal of Parenteral and Enteral Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.